“Discoveries at Weill Cornell have helped revolutionize patient treatment. Our neurosurgical team has created and designed many treatment models that are now used routinely around the world.”— Philip E. Stieg, Ph.D., M.D., Professor of Neurological Surgery, Chairman of the Department of Neurological Surgery
Michael G. Kaplitt, M.D., Ph.D., Associate Professor of Neurological Surgery in Neurology and Otorhinolaryngology, performing the first gene therapy for Parkinson's disease.
Weill Cornell Medical College leads the way in groundbreaking research in brain health—a critical area of the Discoveries Campaign. As people live longer, the need for neurological care will increase significantly over the next 20 years.
Our physician - scientists are pioneers in this field. They successfully conducted the first gene therapy for Parkinson's disease, which strikes 50,000 new people in the U.S. each year. Our researchers have identified naturally occurring antibodies in human blood that may help defend against the development of Alzheimer's disease, which affects about one in every 10 Americans over age 65. They are exploring new frontiers for the causes and treatment of stroke, which affects 700,000 Americans each year. Every day our researchers in the lab and our physicians working with patients make strides that deepen our understanding of the basic biology of the brain.